Pacira BioSciences Reports First Quarter 2019 Revenues of $91.3 Million
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall St on track for subdued September start as high yields, oil prices dent sentiment
- Oil up more than 2% as renewed US-Iran strikes stoke supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- The Warsh pivot markets didn't expect
- Oil settles up by more than 2.5% as US and Iran resume military attacks
Pacira Pharma (PCRX) Misses Q1 EPS by 4c
May 2, 2019 8:17 AM EDTPacira Pharma (NASDAQ: PCRX) reported Q1 EPS of $0.22, $0.04 worse than the analyst estimate of $0.26. Revenue for the quarter came in at $91.3 million versus the consensus estimate of $91.69 million.
2019 Financial Guidance
Pacira updated its 2019 financial guidance to include net product sales of iovera° (from the... More
